Showing 8,801 - 8,820 results of 18,335 for search 'significantly ((((((step decrease) OR (nn decrease))) OR (a decrease))) OR (observed decrease))', query time: 0.74s Refine Results
  1. 8801

    Table 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.docx by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  2. 8802

    Image 3_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.jpeg by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  3. 8803

    Image 1_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  4. 8804

    Image 2_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  5. 8805

    Image 4_Efficacy and safety of levetiracetam in preventing postoperative seizures in adult patients with brain tumors: a meta-analysis.tif by Yongyi Zhang (1800337)

    Published 2025
    “…Subgroup analyses revealed that the efficacy of levetiracetam was superior to that of sodium valproate (OR 0.53, 95% CI 0.39–0.72, p < 0.0001) and phenytoin sodium (OR 0.35, 95% CI 0.19–0.62, p = 0.0004). No statistically significant difference in the efficacy of early seizure prophylaxis (OR 0.55, 95% CI 0.15–2.04, p = 0.37) was observed. …”
  6. 8806

    Supplementary file 3_Efficacy of Xiaoyao-san preparations in treating Hashimoto’s thyroiditis: a meta-analysis and systematic review.docx by Chengna Wang (21535973)

    Published 2025
    “…</p>Methods<p>Eight databases were searched for randomized controlled trials (RCTs) comparing XYS preparations to a low-iodine diet (LID), selenium yeast (SY), levothyroxine (LT4), or Ophiocordyceps sinensis (OS) for HT treatment. …”
  7. 8807

    Supplementary file 2_Efficacy of Xiaoyao-san preparations in treating Hashimoto’s thyroiditis: a meta-analysis and systematic review.zip by Chengna Wang (21535973)

    Published 2025
    “…</p>Methods<p>Eight databases were searched for randomized controlled trials (RCTs) comparing XYS preparations to a low-iodine diet (LID), selenium yeast (SY), levothyroxine (LT4), or Ophiocordyceps sinensis (OS) for HT treatment. …”
  8. 8808

    Supplementary file 1_Efficacy of Xiaoyao-san preparations in treating Hashimoto’s thyroiditis: a meta-analysis and systematic review.zip by Chengna Wang (21535973)

    Published 2025
    “…</p>Methods<p>Eight databases were searched for randomized controlled trials (RCTs) comparing XYS preparations to a low-iodine diet (LID), selenium yeast (SY), levothyroxine (LT4), or Ophiocordyceps sinensis (OS) for HT treatment. …”
  9. 8809

    GRADE judgements. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  10. 8810

    Basic characteristics of the included studies. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  11. 8811

    The data of meta-analysis. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  12. 8812

    Risk of bias. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  13. 8813

    Overall risk of bias assessment. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  14. 8814

    Funnel plot of VO<sub>2Peak</sub> inclusion studies. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  15. 8815

    Analysis of subgroups. by Da Huang (1306407)

    Published 2025
    “…Furthermore, there was no significant difference in the change in resting heart rate (RHR) (MD = 2.04, 95% CI: −2.71–6.78; P = 0.40) between the physical activity group and the control group, but there was a significant difference in the change in maximum heart rate (HR-max) (MD = 6.27, 95% CI: 1.75–10.97, P = 0.007). …”
  16. 8816
  17. 8817

    Table 1_Propolis supplementation on inflammatory and oxidative stress biomarkers in adults: a systematic review and meta-analysis of randomized controlled trials.docx by Hossein Bahari (16704768)

    Published 2025
    “…This meta-analysis revealed that propolis consumption led to a significant decrease in C-reactive protein (CRP) (WMD: –1.23; 95%CI: –1.76, –0.69; p < 0.001), Interleukin-6 (IL-6) (WMD: –1.52; 95%CI: –2.10, –0.93; p < 0.001), Tumor necrosis factor-α (WMD: –1.15; 95%CI: –1.75, –0.55; p < 0.001), and Monocyte chemoattractant protein-1 (MCP-1) (WMD: –35.33; 95%CI: –50.28, –20.37; p < 0.001), and a significant increase in total antioxidant capacity (TAC) (WMD: 0.32; 95%CI: 0.12, 0.51; p = 0.001), Glutathione (GSH) (WMD: 4.71; 95%CI: 3.17, 6.25; p < 0.001), and Glutathione peroxidase (GPx) (WMD: 44.75; 95%CI: 5.10, 84.40; p = 0.02). …”
  18. 8818

    Data Sheet 1_Fungal planktonic community related to salinity and temperature in an oligotrophic sea.docx by Ashwag A. Asseri (20633438)

    Published 2025
    “…Overall, our study described a differential distribution of the most dominant fungal classes, with potential significance in their control of planktonic populations and consequent influence in the carbon cycle in the Red Sea ecosystem. …”
  19. 8819

    Proposed model of how morphological plasticity contributes to echinocandin tolerance acquisition in <i>C. tropicalis</i> clinical isolates. by Yongqin Wu (272012)

    Published 2025
    “…In contrast, non-tolerant strains swell or even rupture, accompanied by a significant thickening of the cell wall, and a marked increase in both chitin and glucan content. …”
  20. 8820